Background & Objectives Antineoplastic agents (AAs) are drugs commonly used to treat cancers and other health conditions, and are found in various work environments. Occupational exposure to AAs has been associated with genotoxic effects and increased risks of reproductive outcomes and cancer. However, information describing the location and extent of occupational contact with AAs is unavailable at national and provincial/territorial levels in Canada. CAREX Canada is a national surveillance project that uses existing data sources to estimate exposure to known and suspected carcinogens. Our objectives for this study were to estimate the prevalence and relative levels of occupational exposures to AAs in Canada across work settings, occupations, and sex. Methods Potentially exposed occupations were identified from the literature. Baseline numbers of licensed workers (nurses, pharmacists, physicians, and veterinarians) were obtained from their respective professional bodies. For inconsistently licensed or unlicensed workers (pharmacy/veterinary technicians, cleaners, laundry workers, and home care workers), Census data or data extrapolated from human resources reports (e.g., staffing ratios) were used. Prevalence was estimated by combining population estimates with exposure proportions from other sources, i.e., peer-reviewed and grey literature. Relative exposure levels (low, moderate, and high) by occupation and work setting were estimated by combining estimates of contact frequency and typical exposure controls in place. Results Approximately 75,000 Canadians are estimated as occupationally exposed to AAs; over 75% are female. The largest occupational group exposed to AAs is community pharmacy staff (pharmacists and technicians), with 30,200 workers exposed. By work setting, 38,200 workers (51% of all exposed) are located in non-hospital settings; the remaining 49% are exposed in hospitals. The majority (75%) of workers exposed to AAs are in the moderate exposure category. Conclusions These estimates provide insight into the prevalence and location of occupational exposures to AAs in Canada. Such information can be used to identify high-risk groups, estimate disease burden, and target prevention activities. The limited secondary data available for developing these estimates points to the need for increased measurement and documentation of AA contamination and exposure. Such new data could be used to more effectively characterize exposure prevalence and intensity, particularly in emerging uses outside of hospitals.
|